Is Privia Health Stock a Good Investment?

Privia Health Investment Advice

  PRVA
To provide specific investment advice or recommendations on Privia Health Group stock, we recommend investors consider the following general factors when evaluating Privia Health Group. This will help you to make an informed decision on whether to include Privia Health in one of your diversified portfolios:
  • Examine Privia Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Privia Health's leadership team and their track record. Good management can help Privia Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Privia Health's business and its evolving consumer preferences.
  • Compare Privia Health's performance and market position to its competitors. Analyze how Privia Health is positioned in terms of product offerings, innovation, and market share.
  • Check if Privia Health pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Privia Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Privia Health Group stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Privia Health Group is a good investment.
 
Sell
 
Buy
Sell
Our recommendation module complements current analysts and expert consensus on Privia Health. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Privia Health is not overpriced, please check all Privia Health Group fundamentals, including its number of shares shorted, cash per share, price to earnings to growth, as well as the relationship between the gross profit and book value per share . Given that Privia Health Group has a number of shares shorted of 5.62 M, we recommend you to check out Privia Health Group market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance

InsignificantDetails

Volatility

Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very SmallDetails

Economic Sensitivity

Actively responds to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails

Examine Privia Health Stock

Researching Privia Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 90.0% of the company shares are owned by institutional investors. The book value of Privia Health was at this time reported as 5.13. The company had not issued any dividends in recent years.
To determine if Privia Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Privia Health's research are outlined below:
Privia Health Group is unlikely to experience financial distress in the next 2 years
Privia Health Group has a strong financial position based on the latest SEC filings
Over 90.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 2320 shares by Mountcastle David of Privia Health at 18.42 subject to Rule 16b-3

Privia Health Quarterly Good Will

139.46 Million

Privia Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Privia Health Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Privia Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Privia Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Privia Health's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-300.050.03-0.0240 
2024-08-08
2024-06-300.050.03-0.0240 
2024-02-27
2023-12-310.040.02-0.0250 
2022-03-22
2021-12-31-0.13-0.110.0215 
2021-11-08
2021-09-30-0.11-0.090.0218 
2021-05-27
2021-03-310.040.060.0250 
2024-05-09
2024-03-310.050.02-0.0360 
2023-05-04
2023-03-310.020.060.04200 

Know Privia Health's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Privia Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Privia Health Group backward and forwards among themselves. Privia Health's institutional investor refers to the entity that pools money to purchase Privia Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-06-30
1.6 M
Franklin Resources Inc2024-09-30
1.3 M
Dimensional Fund Advisors, Inc.2024-09-30
1.3 M
Norges Bank2024-06-30
1.3 M
Northern Trust Corp2024-09-30
1.2 M
Millennium Management Llc2024-06-30
1.1 M
Charles Schwab Investment Management Inc2024-09-30
1.1 M
Bellevue Group Ag2024-09-30
1.1 M
Loomis, Sayles & Company Lp2024-06-30
916.8 K
Fmr Inc2024-09-30
18.2 M
Blackrock Inc2024-06-30
17.3 M
Note, although Privia Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Privia Health's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.58 B.

Market Cap

2.93 Billion

Privia Health's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Capital Employed 0.03  0.04 
Return On Assets 0.02  0.02 
Return On Equity 0.04  0.04 
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.
Determining Privia Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Privia Health is a good buy. For example, gross profit margin measures Privia Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Privia Health's profitability and make more informed investment decisions.
Please note, the presentation of Privia Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Privia Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Privia Health's management manipulating its earnings.

Evaluate Privia Health's management efficiency

The current year's Return On Tangible Assets is expected to grow to 0.03. The current year's Return On Capital Employed is expected to grow to 0.04. At present, Privia Health's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 54.4 M, whereas Total Current Assets are forecasted to decline to about 391.3 M. Privia Health's management efficiency ratios could be used to measure how well Privia Health manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 5.20  5.46 
Tangible Book Value Per Share 3.09  3.25 
Enterprise Value Over EBITDA 84.88  163.35 
Price Book Value Ratio 4.79  4.55 
Enterprise Value Multiple 84.88  163.35 
Price Fair Value 4.79  4.55 
Enterprise Value2.3 B2.6 B
The leadership approach at Privia Health's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta
0.761

Basic technical analysis of Privia Stock

As of the 28th of November, Privia Health holds the Risk Adjusted Performance of 0.0214, coefficient of variation of 5383.16, and Semi Deviation of 2.29. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Privia Health, as well as the relationship between them.

Privia Health's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Privia Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Privia Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Privia Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Mountcastle David 3 days ago
Disposition of 2320 shares by Mountcastle David of Privia Health at 18.42 subject to Rule 16b-3
 
Thomas Bartrum over two weeks ago
Disposition of 10634 shares by Thomas Bartrum of Privia Health at 26.3 subject to Rule 16b-3
 
Mccarthy Thomas A over three weeks ago
Acquisition by Mccarthy Thomas A of 7758 shares of Privia Health subject to Rule 16b-3
 
Parth Mehrotra over two months ago
Disposition of 16144 shares by Parth Mehrotra of Privia Health at 2.0 subject to Rule 16b-3
 
Parth Mehrotra over two months ago
Disposition of 18595 shares by Parth Mehrotra of Privia Health at 2.0 subject to Rule 16b-3
 
Parth Mehrotra over two months ago
Acquisition by Parth Mehrotra of 16144 shares of Privia Health at 2.0 subject to Rule 16b-3
 
Matthew Morris over three months ago
Acquisition by Matthew Morris of 154676 shares of Privia Health at 2.0 subject to Rule 16b-3
 
Mccarthy Thomas A over three months ago
Disposition of 41487 shares by Mccarthy Thomas A of Privia Health subject to Rule 16b-3
 
Sullivan William M over three months ago
Disposition of 7115 shares by Sullivan William M of Privia Health at 23.03 subject to Rule 16b-3
 
Boehler Adam over three months ago
Acquisition by Boehler Adam of 364 shares of Privia Health at 16.5 subject to Rule 16b-3
 
Boehler Adam over six months ago
Acquisition by Boehler Adam of 4280 shares of Privia Health at 16.49 subject to Rule 16b-3
 
Cocozza Nancy G over six months ago
Acquisition by Cocozza Nancy G of 11124 shares of Privia Health subject to Rule 16b-3

Privia Health's Outstanding Corporate Bonds

Privia Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Privia Health Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Privia bonds can be classified according to their maturity, which is the date when Privia Health Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Privia Health's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Privia Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Privia Health's intraday indicators

Privia Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Privia Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Privia Health Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
12th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
29th of May 2024
An amendment to a previously filed Form 8-K
ViewVerify
Privia Health time-series forecasting models is one of many Privia Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Privia Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Privia Stock media impact

Far too much social signal, news, headlines, and media speculation about Privia Health that are available to investors today. That information is available publicly through Privia media outlets and privately through word of mouth or via Privia internal channels. However, regardless of the origin, that massive amount of Privia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Privia Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Privia Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Privia Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Privia Health alpha.

Privia Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Privia Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Privia Health Corporate Management

Dana CPASenior OfficerProfile
Chris VoigtExecutive OfficerProfile
Jim MDCEO TennesseeProfile
Thomas BartrumExecutive CounselProfile
Robert BorchertSenior CommunicationsProfile
Jay StevensSenior OfficerProfile
When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Privia Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.38)
Earnings Share
0.11
Revenue Per Share
14.435
Quarterly Revenue Growth
0.049
Return On Assets
0.0077
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Privia Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.